EXHIBIT 31.2
                                  CERTIFICATION

         I, Mark I. Gittelman, certify that:

1.       I have  reviewed  this  annual  report on Form 10-K for the year  ended
March 31, 2006 of Elite Pharmaceuticals, Inc. (the "registrant");

2.       Based  on my  knowledge,  this  report  does  not  contain  any  untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the period covered by this report;

3.       Based on my knowledge,  the financial  statements,  and other financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.       The  registrant's  other  certifying  officer and I are responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules  13a-15(e) and 15d-15(e) and internal  control over financial
reporting  (as defined in Exchange Act Rules  13a015(f) and  15d-15(f))  for the
registrant and have:

(a)      Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

(b)      Designed such internal control over financial reporting, or caused such
internal control over financial  reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial  statements for external purposes in accordance
with generally accepted accounting principles;

(c)      Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

(d)      Disclosed  in this  report  any  change  in the  registrant's  internal
control over financial  reporting that occurred during the  registrant's  fourth
fiscal  quarter  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the registrant's internal control over financial reporting.

5.       The registrant's other certifying  officer and I have disclosed,  based
on our most recent evaluation of internal control over financial  reporting,  to
the registrant's  auditors and the audit committee of the registrant's  board of
directors (or persons performing the equivalent functions):

(a)      All significant  deficiencies and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  registrant's  ability  to  record,  process,
summarize and report financial information; and

(b)      Any fraud,  whether or not material,  that involves management or other
employees who have a significant role in the registrant's  internal control over
financial reporting.

Date:  June 29, 2006                  /s/ Mark I. Gittelman
                                      ------------------------------------
                                      Mark I. Gittelman,
                                      Chief Financial Officer and Treasurer